Literature DB >> 7250142

Structural parameters in the microsomal hydrolysis of 3-acyloxy-1, 4-benzodiazepines and the multiplicity of the esterases involved.

G Maksay, Z Tegyey, E Simon-Trompler, L Otvös.   

Abstract

The biotransformation of several prodrug-type esters of centrally acting 1, 4-benzodiazepines was studied. Their rates of hydrolysis catalyzed by the hepatic microsomal fraction of mice were measured by pH-stat. The heterogeneity of the microsomal esterases was investigated with induction by phenobarbital and with inhibition by DFP. The resulting changes in esterase activity indicated that the phenyl-substituted esters separate from the homogenous sets of oxazepam and lorazepam esters. Regression analysis of the relative hydrolysis rates of the homogenous ester sets revealed a similar dependence on the steric ES the polar sigma* and hydrophobic deltaRM terms of the acyl moiety. The role of the polar term shows that a nucleophilic attack of the acyl moiety determines the hydrolysis. The role of hydrophobicity can be attributed to its interrelation with the steric parameter. The common equations for the aliphatic sters of oxazepam and larazepam suggest the similar nature of the esterases in question and the same catalytic mechanism. Different 3-acetoxy-1, 4-benzodiazepines were also synthetised and their maximal hydrolysis rates were quite different. This excludes the possibility that the deacylation step of the enzymes is rate-determining. Instead, our data suggest that acylation of the microsomal esterases is rate-limiting for the hydrolysis of the aliphatic esters of 3-OH-benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7250142     DOI: 10.1007/BF03189464

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  20 in total

1.  ABSORPTION, METABOLISM, AND EXCRETION OF OXAZEPAM AND ITS SUCCINATE HALF-ESTER.

Authors:  S S WALKENSTEIN; R WISER; C H GUDMUNDSEN; H B KIMMEL; R A CORRADINO
Journal:  J Pharm Sci       Date:  1964-10       Impact factor: 3.534

2.  Application of the Weichselbaum biuret reagent to the determination of spinal fluid protein.

Authors:  M DITTEBRANDT
Journal:  Am J Clin Pathol       Date:  1948-05       Impact factor: 2.493

3.  Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. VI. Different substrate specificities of the cytochrome P450 fractions from control and phenobarbital-treated rats.

Authors:  A Y Lu; W Levin; S B West; M Jacobson; D Ryan; R Kuntzman; A H Conney
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

4.  Interdependence between physical parameters and selection of substituent groups for correlation studies.

Authors:  P N Craig
Journal:  J Med Chem       Date:  1971-08       Impact factor: 7.446

5.  Structure--activity correlations in the metabolism of drugs.

Authors:  C Hansch; E J Lien; F Helmer
Journal:  Arch Biochem Biophys       Date:  1968-11       Impact factor: 4.013

6.  Kinetic investigations of liver microsomal esterases with oxazepam esters.

Authors:  G Maksay; Z Tegyey; L Otvös
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1978-08

7.  QSAR in drug metabolism and disposition. An application to the affinity for cytochrome P-450 and hepatic clearance of barbiturates.

Authors:  B Testa
Journal:  Pharm Acta Helv       Date:  1978

8.  Electron capture and multiple ion detection of benzodiazepine esters in pharmacokinetic studies.

Authors:  M C Sánchez; J Colomé; E Gelpí
Journal:  J Chromatogr       Date:  1976-11-03

9.  Effects of enzyme induction and inhibition on microsomal oxidation of 1,4-benzodiazepines.

Authors:  H J Schwandt; W Sadée; K H Beyer; A G Hilderbrandt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-07       Impact factor: 3.000

10.  A double-blind cross-over evaluation of the activity of d-oxazepam hemisuccinate sodium salt (D-7-chloro-1,3-dihydro-3-hemisuccinyloxy-5-phenyl-2H-1,4-benzodiazepine-2-one) compared to its racemic form.

Authors:  M Lescovelli; A Castellani; D Perbellini
Journal:  Arzneimittelforschung       Date:  1976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.